Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction-Reference-Cited by-同舟云学术

Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction

Published:2016-10-18 Issue:1 Volume:4 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Kanz Bridgette A.,Pollack Megan H.,Johnpulle Romany,Puzanov Igor,Horn Leora,Morgans Alicia,Sosman Jeffrey A.,Rapisuwon Suthee,Conry R. Martin,Eroglu Zeynep,Johnson Douglas B.

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-016-0166-5.pdf

Reference18 articles.

1. Robert C, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med. 2015;372(4):320–30.

2. Robert C, et al. Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med. 2015;372(26):2521–32.

3. Motzer RJ, et al. Nivolumab versus everolimus in advanced renal-cell carcinoma. N Engl J Med. 2015;373(19):1803–13.

4. Garon EB, et al. Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med. 2015;372(21):2018–28.

5. Herbst RS, et al. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet. 2016;387(10027):1540–50.

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful treatment with nivolumab in a patient with gastric cancer with severe liver failure resulting from multiple liver metastases: A case report;Oncology Letters;2024-04-18

2. Nivolumab treatment in a patient with BRAF mutant advanced melanoma and liver failure with encephalopathy;Journal of Oncology Pharmacy Practice;2023-12-18

3. Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-11

4. Insuffisance d’organe (cœur, rein, foie) et traitements du cancer pulmonaire;Revue des Maladies Respiratoires Actualités;2023-10

5. A retrospective analysis of immune checkpoint inhibitors in patients with preexisting organ dysfunction;Cancer;2023-08-07